Login here
Register Free
Virtual Events
Sponsored By

For information on becoming a sponsor or exhibitor, please click here.

OCT 12 2017 - OCT 13 2018
Stago EdVantage Virtual University
23 50 19955



 

Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that explore basic and complex concepts, making them accessible to novices as well as experienced users.  In an ever evolving landscape of research and publication, it can be challenging to stay current. By listening to industry key opinion leaders and Stago experts, you can be assured of staying informed of the latest best practices.

Benefits of the Stago EdVantage Virtual University comprehensive online webcast library include being able to access programs 24/7, participate in complete trainings on-the-go with our mobile compatible platform, train at your leisure with stop and start capability, and receive instantaneous training certificates upon completion.  With Stago EdVantage Virtual University, you can maintain education and accreditation requirements at no cost, on demand and on your schedule, so you can participate more frequently and implement new tools more rapidly.
 
Diagnostica Stago has long placed a high priority on hemostasis education. We are glad you have chosen to attend Stago EdVantage Virtual University.

Speakers:
  • Keri Anderson, Pharm D, BCPS
    Clinical Pharmacist in the Commercial and Specialty Pharmacy Division, Florida Blue
  • Lynn Boshkov, MD
    Prof. of Pathology, Medicine & Pediatrics Director of Hemostasis & Thrombosis, Oregon Health & Science University (OHSU)
  • Leonardo Brandao, MD, Msc
    Associate Professor of Pediatrics, University of Toronto, Hemostasis and Thrombosis Service, The Hospital for Sick Children
  • Donna Castellone, MS, MASCP, MT(ASCP) SH
    QA Manager for Specialty Testing and Supervisor, Special Coagulation and Special Hematology, New York Presbyterian Hospital
  • Meera Chitlur, MD
    Professor of Pediatrics, Hematology & Oncology, Wayne State University School of Medicine
  • James Groce III, Pharm. D, CACP
    Professor, Department of Pharmacy Practice, Campbell University School of Pharmacy, Clinical Assistant Professor of Medicine, University of North Carolina School of Medicine, Clinical Pharm
  • Michael Gulseth, PharmD, BCPS, FASHP
    Program Director for Anticoagulation Services, Sanford USD Medical Center & Clinical,Associate Professor, Dept of Internal Medicine, University of South Dakota Sanford School of Medicine
  • Neil Harris, MD
    Associate Professor, College of Medicine Department of Pathology, Immunology and Laboratory Medicine, University of Florida
  • Eleanor Herriman, MD, MBA
    Chief Medical Informatics Officer, Viewics, Inc.
  • Christopher Kabrhel, MD, MPH
    Associate Professor of Surgery, Harvard Medical School
  • Tatsiana Mardovina, MD, PhD
    Scientific Market Development, Diagnostica Stago, Inc.
  • Richard Marlar, PhD
    Professor of Pathology Chief, Clinical Pathology, VA Medical Center, Department of Pathology, University of Oklahoma Health Sciences Center
  • John Mitsios, PhD
    Assistant Director, Special Coagulation Laboratory, BioReferance Laboratories
  • Stephan Moll, MD
    Professor of Medicine, UNC-Chapel Hill Hemophilia & Thrombosis Center
  • Gabrielle Pearl, MT(ASCP)
    Manager, Hematology & Flow Cytometry Department of Pathology & Laboratory Medicine, Children's Hospital Colorado
  • Suman Wasan, MD, MS, FACP
    Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
  • Paul Riley, PhD, MBA
    Scientific Business Development Manager, Diagnostica Stago, Inc.
  • Jeremy Vandiver, Pharm D, BCPS
    Clinical Assistant Professor of Pharmacy Practice, University of Wyoming School of Pharmacy
  • Oksana Volod, MD
    Director, Coagulation Consultative Service Director, Pathology and Laboratory Medicine Residency Program, Associate Professor, Cedars Sinai Medical Center
Show Resources
Webinars

Stago is committed to providing you with the latest relevant information regarding new tests, new markers or key assays in the field of Thrombosis and Haemostasis. Educational sessions are provided by healthcare professionals and international world-renowned experts in the field. 

Click below each speaker's photo to watch their Webcast
Speakers
  • Keri Anderson, Pharm D, BCPS
    Clinical Pharmacist in the Commercial and Specialty Pharmacy Division, Florida Blue
    Biography
      Keri is a Clinical Pharmacist in the Commercial and Specialty Pharmacy Division at Florida Blue where she primarily establishes and maintains medical coverage guidelines for specialty medications. Keri previously worked as an Assistant Professor in the Department of Pharmacy Practice at South University from 2010 to 2015. She coordinated and lectured in courses including Communications, Quality Improvement and Patient Safety, Professional Practice and Informatics, and Drug Information. She precepted residents and students in the Drug information center and established a clinical practice site for students in Internal Medicine at Southeast Georgia Regional Health System. Keri completed an ASHP accredited PGY1 residency at Shands Jacksonville and a PGY2 specialty residency in Drug Information at South University, with accompanying activities at Memorial University Medical Center, St. Joseph's/Candler Hospital, and NorthStar Healthcare Consulting. Prior to attending pharmacy school at South University, Keri worked as a software consultant in informatics for Cerner Corporation from 2001 to 2005. Keri is an active member of GSHP and serves as the Southeast District Director coordinating district meetings in the Savannah and St. Simons area. She previously served as co-chair of the GSHP Education Committee from 2011 to 2014. Keri is also a member of ACCP, ASHP, AACP, the American Cancer Society Victory Board, Auxiliary of Hospice of the Golden Isles, and the Golden Isles UGA Alumni Association.
    • Lynn Boshkov, MD
      Prof. of Pathology, Medicine & Pediatrics Director of Hemostasis & Thrombosis, Oregon Health & Science University (OHSU)
      Biography
        Dr. Boshkov specializes in coagulation abnormalities and testing, and blood transfusion, including support of Jehovah's Witness patients. She is the principal investigator in clinical trials to determine if the use of prestorage leukoreduced blood products modifies the outcome in cardiac surgery patients. Dr. Boshkov heads hemostasis and thrombosis at OHSU, and is the associate director of transfusion medicine. She is married with two sons, and is fluent in French.
      • Leonardo Brandao, MD, Msc
        Associate Professor of Pediatrics, University of Toronto, Hemostasis and Thrombosis Service, The Hospital for Sick Children
        Biography
          Dr. Leonardo Brandao is a native Brazilian who obtained his medical degree at University of Sao Paulo (USP). After doing post-graduate training at the same institution, he pursued training in North America in Pediatrics (Emory University, Atlanta, Georgia), Pediatric Hematology/Oncology (St. Jude Children's Research Hospital, Memphis, Tennessee) and Pediatric Coagulation (Weill Cornell University, New York, New York). In brief, his North American training initially included a fellowship at St. Jude's Children's Research Hospital, where he was actively involved in studying clinical coagulation laboratory tools in children with acute lymphoid leukemia, as well as working in a gene therapy laboratory to study the expression of antithrombin by different cell lines. This was followed by training in pediatrics/coagulation (Emory University), where he developed and coordinated research projects on bleeding (pediatric bleeding score, platelet function defects). During his second fellowship training at Weill Cornell University, his research was solely focused on pediatric coagulation, in the management of both bleeding (new laboratory tools for phenotype definition in hemophilia) and thrombosis (the role of inherited thrombophilia in venous thrombosis) in children. He is currently a staff member with the Hemostasis and Thrombosis Service. This is Canada's largest referral based-tertiary hospital. Because of its' privileged position in the field of pediatric thrombosis, Sickkids® continues to be instrumental in the development of the field of pediatric thrombosis, by participating in several dose finding studies for several of the new anticoagulants in children, as well as other prospective clinical research studies (i.e. perfusion medicine, cardiology, pediatric thrombosis). Dr. Brandao is also actively involved in the field of coagulation in children with congenital heart defects, in the area of long-term thrombosis outcome (i.e. post-thrombotic syndrome), and in the subject of coagulation derangements in children with vascular anomalies.
        • Donna Castellone, MS, MASCP, MT(ASCP) SH
          QA Manager for Specialty Testing and Supervisor, Special Coagulation and Special Hematology, New York Presbyterian Hospital
          Biography
            Donna is Quality Assurance (QA) Manager for Specialty Testing and Supervisor, Special Coagulation and Special Hematology at New York Presbyterian Hospital- Columbia in New York City. She has 34 years clinical laboratory experience, 6 years industry clinical trial experience, including PhD work on Standardization of Laboratory Testing (all but dissertation). Donna has written several book chapters, many publications and presented many coagulation lectures to diverse audiences at all levels of expertise. She is adjunct professor at York College and Rutgers University. Donna presently serves on the Executive Committee of the North American Specialized Coagulation Laboratory Association (NASCOLA) as a Secretary, Publication Committee and Pre-Curriculum Committee for the American Society for Clinical Pathology (ASCP), and the Expert Committee for Hematology for the Clinical Laboratory Standards Institute (CLSI). She is also a member of International Society on Thrombosis and Haemostasis (ISTH), International Society for Laboratory Hematology (ISLH) and ASCP.
          • Meera Chitlur, MD
            Professor of Pediatrics, Hematology & Oncology, Wayne State University School of Medicine
            Biography
              Dr. Meera Chitlur is Professor of Pediatrics and Barnhart-Lusher Hemostasis Research Endowed Chair at Wayne State University School of Medicine and practices in the Division of Hematology/Oncology at the Children's Hospital of Michigan. She is the Director of the Hemophilia and Hemostasis Treatment Center and The Jeanne M.Lusher Special Coagulation Clinical Research Laboratory at Children's Hospital of Michigan. She earned her MBBS degree at Kempegowda Institute of Medical Sciences in Bangalore, India and completed her postgraduate training as a pediatric resident at Henry Ford Hospital in Detroit, MI. She then completed her fellowship in Pediatric Hematology/Oncology at Children's Hospital of Michigan. Dr.Chitlur is a member of the American Society of Hematology (ASH), Hemophilia and Thrombosis Research Society (HTRS), and International Society of Thrombosis and Hemostasis (ISTH). She was elected to membership on the National Hemophilia Foundation's (NHF) Medical and Scientific Advisory Council in 2014, nominated for the 2015 "America's Best Physicians" directory, elected to the HTRS Board of Directors in 2015, selected by peers for inclusion in Hour Detroit Magazine's list of "Top Docs", and won the Resident Teaching award in 2016. Her research interest is in global hemostasis assays, particularly Thromboelastography and Thrombin Generation. She is currently an Internationally recognized expert in Thromboelastography and has written the guidelines for performing Thromboelastography in Hemophilia. Dr. Chitlur has also authored approximately 60 peer reviewed publications, case reports, review articles, editorials, and book chapters.
            • James Groce III, Pharm. D, CACP
              Professor, Department of Pharmacy Practice, Campbell University School of Pharmacy, Clinical Assistant Professor of Medicine, University of North Carolina School of Medicine, Clinical Pharm
              Biography
                James B Groce Ill, PharmD, CACP, is Professor, Department of Pharmacy Practice at Campbell University School of Pharmacy. Dr. Groce also is Clinical Assistant Professor of Medicine at the University of North Carolina School of Medicine and Clinical Pharmacy Specialist-Anticoagulation at the Moses H. Cone Memorial Hospital in Greensboro, North Carolina, where he manages an anticoagulation clinic serving over 100 patients and supervises pharmacy practice and medicine residents training in anticoagulation management at this site. He served as principal investigator at Moses H. Cone Health System for DVT FREE, a national registry trial examining risk factors and prevalence of DW. Additionally, he was part of the II- member steering committee for this initiative. He represents pharmacy nationally on the Council for Leadership on Thrombosis Awareness and Management (CLOT Council) as its sole pharmacist member on this physician-based panel of National thought leaders and experts on thromboembolism as well as the Coalition Against DW in the same capacity. He was recently appointed to the Technical Advisory Panel of JCAHOINQF for creation of core measures for prevention and treatment of venous thromboembolism. Most recently, he was named Preceptor of the Year by the graduating classes of 2006 and 2007, Campbell University School of Pharmacy. Dr. Groce has been published and cited in peer-reviewed medical and pharmacy journals as well as textbooks of pharmacy. He has presented extensively regarding the interchange of Narrow Therapeutic Index Drugs and its impact with respect to efficacy and safety, and pharmacoeconmics; he gave testimony before the state Senate and House Subcommittees of the North Carolina Legislature examining this issue that resulted in Senate Bill 945 - The Prescription Refill Safety Act. He is certified by the National Certification Board of Anticoagulation Providers and currently is a sitting member of its Board of Directors.
              • Michael Gulseth, PharmD, BCPS, FASHP
                Program Director for Anticoagulation Services, Sanford USD Medical Center & Clinical,Associate Professor, Dept of Internal Medicine, University of South Dakota Sanford School of Medicine
              • Neil Harris, MD
                Associate Professor, College of Medicine Department of Pathology, Immunology and Laboratory Medicine, University of Florida
                Biography
                  Dr. Neil S. Harris is board-certified in anatomic and clinical pathology, as well as clinical chemistry through the American Board of Clinical Chemistry. He is currently the director of the core (chemistry/hematology) laboratory, in addition to being a clinical associate professor at the Department of Pathology, Immunology and Laboratory Medicine within the University of Florida's College of Medicine. Dr. Harris received his undergraduate and medical education at the University of Cape Town in South Africa. In the 1980s, his postgraduate training included a residency in clinical pathology (chemical pathology & immunology) in the Division of Pathology at the University of Cape Town. This was followed by a research fellowship in the Division of Hematology/Oncology and a fellowship in clinical chemistry at the Department of Laboratory Medicine at the Children's Hospital in Boston, Massachusetts. He obtained his USA credentials in pathology by completing his residency at Fletcher Allen Health Care in at the University of Vermont in Burlington.
                • Eleanor Herriman, MD, MBA
                  Chief Medical Informatics Officer, Viewics, Inc.
                  Biography
                    L. Eleanor J. Herriman, M.D., M.B.A. is the Chief Medical Informatics Officer at Viewics. She is a physician executive with 20 years of varied healthcare industry experience. Before joining Viewics, Eleanor was a faculty member at Harvard Business School's Institute for Strategy and Competitiveness. Prior career experience includes: market research and strategy services to the pathology and laboratory industries at G2 Intelligence, healthcare strategy consulting at Bain & Company, and multiple startup medical technology ventures. Dr. Herriman holds a Doctor of Medicine degree from Baylor College of Medicine and was awarded the Presidents Scholarship. Dr Herriman also holds a Masters in Business Administration from Harvard University Graduate School of Business Administration as a Baker Scholar and a Bachelors of Science in electrical engineering from Rice University with a minor in bioengineering.
                  • Christopher Kabrhel, MD, MPH
                    Associate Professor of Surgery, Harvard Medical School
                    Biography
                      Dr. Christopher Kabrhel is an attending physician at the Massachusetts General Hospital Department of Emergency Medicine. He graduated from John Hopkins University School of Medicine. He then completed his residency with Harvard Affiliated Emergency Medicine Residency Program (HAEMR) at Brigham and Women's Hospital and Massachusetts General Hospital. Dr. Kabrhel also has his Masters in Public Health from Harvard School of Public Health. He is an associate professor of surgery at Harvard Medical School. He is also a staff researcher at the Channing Laboratory at Brigham and Women's Hospital and holds an appointment at the MGH Institute for Heart, Vascular and Stroke Care, where he is a founding member of the Pulmonary Embolism Response Team (PERT). Dr. Kabrhel has been invited to lecture nationally and internationally on the topic of venous thromboembolic disease and teaches research methodology to emergency medicine residents. In 2002 he co-founded the HAEMR Research Interest Group (RIG) and is currently the faculty liaison to this group. The purpose of the RIG is to provide a forum for collaboration and didactic education to residents interested in clinical research. Dr. Kabrhel is core faculty for HAEMR journal club and a Harvard College summer course focused on technology and innovation.
                    • Tatsiana Mardovina, MD, PhD
                      Scientific Market Development, Diagnostica Stago, Inc.
                      Biography
                        Dr. Mardovina has been employed by Diagnostica Stago, Inc. since October, 2016. As a Scientific Market Development team member, she is responsible for operational functions associated with scientific and market development activities covering the North American Market. She engages with key opinion leaders, clinicians and researchers on scientific and marketing studies. Dr. Mardovina was educated at the Grodno State Medical University in Belarus, where she earned her MD. She then completed a residency in pediatrics before enrolling at the National Scientific and Practical Center "Mother and Child" where she earned her PhD. Dr. Mardovina presented the findings from her research at international meetings and also produced several publications and patents. Her professional interest continuous to be focused on perinatal medicine.
                      • Richard Marlar, PhD
                        Professor of Pathology Chief, Clinical Pathology, VA Medical Center, Department of Pathology, University of Oklahoma Health Sciences Center
                        Biography
                          Richard Marler, Ph.D Dr Marlar is Professor of Pathology at the University of Oklahoma. He serves as the Chief of Clinical Pathology at the Oklahoma City VA Medical Center. He has directed Coagulation Laboratories for 30 years including currently the Coagulation Labs at the University of Oklahoma Medical Center and the Routine and Special Coagulation Laboratories at the Oklahoma City VA. In addition he oversees the Molecular Diagnostics Laboratory at the Oklahoma City VA. He received his PhD from Wayne State University in Biochemistry and Physiology and did a Hemostasis Fellowship at the Scripps Clinic and Research Foundation. He serves on numerous national and international clinical coagulation committees including: CLSI Committee on Coagulation, Director of External Quality Assurance for the North American Special Coagulation Laboratory Association (NASCOLA), Co-Chairman of the ISTH Committee on Plasma Inhibitors, the International External Quality Assessment Program for Thrombosis and Hemostasis, and the CAP Coagulation Resource Committee. He is currently the Editor of the international journal Blood Coagulation and Fibrinolysis . His research focuses on the genetics of venous thrombosis and thrombophilia with special interest in protein C deficiencies. He also conducts translational research for the clinical laboratory. He is the author of over 135 articles, book chapters and monographs.
                        • John Mitsios, PhD
                          Assistant Director, Special Coagulation Laboratory, BioReferance Laboratories
                        • Stephan Moll, MD
                          Professor of Medicine, UNC-Chapel Hill Hemophilia & Thrombosis Center
                          Biography
                            Dr. Moll received his medical degree from Freiburg University, Germany, He completed an internship/residency in internal medicine and a hematology-oncology fellowship at Duke University Medical Center (1989-1996), during which he also did a 1-year clinical coagulation fellowship at the University of North Carolina, Chapel Hill (1994-1995). Dr. Moll's postgraduate career included a position in clinical coagulation in the cardiology division of the Humboldt University in Berlin, Germany (1997-1999). Dr. Moll has been a faculty member at UNC in the Department of Medicine and the Division of Hematology-Oncology since 1999. His clinical focus is coagulation, particularly thrombosis and thrombophilia. Dr. Moll's research interests include clinical trials on new anticoagulants, better use of established anticoagulants, antiphospholipid antibody syndrome and postthrombotic syndrome. He has a major interest in health education of patients, public and health care providers about blood clots and clotting disorders. Since 2001 he has written a Q/A section on thrombosis and thrombophilia for the non-profit website www.fvleiden.org. Dr. Moll is a co-founder of the national patient advocacy group NBCA (National Blood Clot Alliance; www.stoptheclot.org), and a board member of the national non-profit anticoagulation provider organization AC-Forum (Anticoagulation Forum; www.acforum.org). He has authored and coauthored a number of peer-reviewed articles textbook chapters on blood clots. He is the founder of the UNC Blood Clot Education Outreach Program created in 2010.
                          • Gabrielle Pearl, MT(ASCP)
                            Manager, Hematology & Flow Cytometry Department of Pathology & Laboratory Medicine, Children's Hospital Colorado
                            Biography
                              Gabrielle earned her BSMT from the University of Wisconsin - Milwaukee. She has managed clinical laboratories ranging from small satellite laboratories to specialized laboratory sections in large metropolitan hospitals. Gabrielle worked for Poudre Valley Health System for 10 years, was a Technical Support Specialist for Diagnostica Stago for 2 years, followed by managing the hematology section at Children's Hospital Colorado for 5 years. Gabrielle is currently the Sr. Manager of Core Laboratory Operations at Children's Hospital Colorado. She lives in Parker, CO and enjoys spending her time with her family and 2 wire haired miniature dachshunds. University of Wisconsin-Stevens Point BS, Wildlife Mgmt 1987 - 1992
                            • Suman Wasan, MD, MS, FACP
                              Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
                              Biography
                                Suman Rathbun, MD is currently Director of the Vascular Medicine Program at OUHSC as well as director of the vascular laboratories and vascular fellowship at OU Medical Center, Oklahoma City, Oklahoma. Dr. Rathbun has been principal investigator in several research projects regarding pulmonary embolism and deep-vein thrombosis. Dr. Rathbun has published and presented both locally and nationally. She participated on the U.S. Surgeon General's task force for awareness of deep-vein thrombosis in Washington, DC. Currently, she serves as secretary to the Society of Vascular Medicine and chair of the education committee for the Venous Disease Coalition. Suman Rathbun received her doctorate of medicine at the University of Texas at San Antonio, Texas in 1994. Dr. Rathbun received her master's degree in epidemiology at the University of Oklahoma Health Sciences Center in 2004. She is board certified in internal medicine and vascular medicine.
                              • Paul Riley, PhD, MBA
                                Scientific Business Development Manager, Diagnostica Stago, Inc.
                                Biography
                                  Paul earned a PhD in biochemistry from Temple University in 2006, with the subject of the dissertation regarding the function of coagulation factor XI. He also did postdoctoral training in a related area before becoming a product manager and scientific affairs specialist in 2009. During his time at Stago, Paul also completed an MBA degree program at Cornell University in 2014. He has spoken to dozens of medical technologist, clinical laboratory scientist, pharmacist and clinician audiences about various topics within hemostasis and coagulation. He also has a great interest in working with clinical pathologists, pharmacists, basic scientists, and pharmaceutical researchers to perform studies and publish, contributing to advancement of the hemostasis and coagulation science.
                                • Jeremy Vandiver, Pharm D, BCPS
                                  Clinical Assistant Professor of Pharmacy Practice, University of Wyoming School of Pharmacy
                                  Biography
                                    Dr. Vandiver joined the University of Wyoming School of Pharmacy in July 2012 as a Clinical Assistant Professor of Pharmacy Practice. Upon graduating from the University of Colorado Health Sciences Center with a Doctor of Pharmacy in 2010, he completed a PGY1 pharmacy practice residency at Exempla Saint Joseph Hospital, located in Denver, Colorado. Dr. Vandiver then went on to complete a PGY2 internal medicine specialty residency, also at Exempla Saint Joseph Hospital. He is a Board Certified Pharmacotherapy Specialist. His current practice site is at Swedish Medical Center in Englewood, Colorado, practicing as an inpatient clinical pharmacist with the Swedish Family Medicine Residency Program. His academic interests include anticoagulation, pain management, cardiology, and transitions of care. Dr. Vandiver offers internal medicine rotations at Swedish Medical Center.
                                  • Oksana Volod, MD
                                    Director, Coagulation Consultative Service Director, Pathology and Laboratory Medicine Residency Program, Associate Professor, Cedars Sinai Medical Center
                                    Biography
                                      Dr. Oksana Volod is a pathologist in West Hollywood, California and is affiliated with Cedars-Sinai Medical Center. She received her medical degree from Uzhhorod National University Faculty of Medicine and has been in practice for more than 20 years. She is one of 46 doctors at Cedars-Sinai Medical Center who specialize in Pathology.
                                    Continuing Education (CME/CE/CEU) Credits

                                    The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

                                    Help

                                    General LabRoots Questions

                                    For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                    Contact us

                                    Virtual Events and Webinars

                                    Supported Configurations

                                    • Operating System Internet Explorer Firefox Chrome Safari
                                      Vista IE8+ FF10+ Chrome15+
                                      Windows 7 IE8+ FF10+ Chrome15+
                                      Windows 8 IE10 FF10+ Chrome15+
                                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                                    • Cookie settings: session cookies enabled
                                    • Browser configuration must have JavaScript enabled
                                    • Adobe Flash player 10.2 or later

                                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                    Internet Connection

                                    • A minimum of 100Kbps is recommended for audio-only events
                                    • A minimum of 300Kbps is recommended for speaker on-video events

                                    Computer Equipment

                                    • Screen Resolution: Minimum 1024x768
                                    • Video Card: 65,000 colors minimum
                                    • Sound card and speakers (or headphones) for hearing webcast in full format
                                    • Audio Card: 16-bit minimum
                                    • RAM: 512MB of free RAM

                                    Firewall Protocol

                                    • HTTP on port 80 or HTTPS on port 443
                                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                    Work-At-Home Attendees

                                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                    For A Seamless Experience

                                    When using a mobile device, FREE Mobile Apps are available:

                                    - For viewing Webinars:

                                    - For viewing Virtual Events

                                    Attendee Guide

                                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                    Virtual Event and Webinar Support:

                                    Continuing Education (CME/CE) Support

                                    Loading Comments...
                                    Show Resources
                                    Attendees
                                    INVITE COLLEAGUES
                                    • Upcoming Webinars
                                    Science T-Shirts
                                    • Popular Articles